Medscape is available in 5 Language Editions – Choose your Edition here.


Pediatric Malabsorption Syndromes Clinical Presentation

  • Author: Stefano Guandalini, MD; Chief Editor: Carmen Cuffari, MD  more...
Updated: Jul 17, 2015


The following are important to assess in patients with possible malabsorption syndromes:

  • Diet history: Obtain a complete history of the patient's diet, including the amount and type of fluids, solid foods, and formula ingested. Caregivers should keep a detailed journal of the patient's diet and symptoms for a minimum of 1 week.
    • The proper amount of fluid for most young children is around 100 mL/kg/d. Fluid intake that exceeds this amount may result in looser stools, which causes a referral for a suspected but nonexistent malabsorption.
    • Fat is important for slowing the movement of food through the intestine via hormonal mechanisms. Fat intake of less than 3 g/kg/d may contribute to toddler's diarrhea, especially in the setting of excessive free fluid and carbohydrate intake (eg, as occurs with large amounts of fruit juice intake). Thus, history is important in differentiating the common toddler's diarrhea from the rarer malabsorption syndromes.
    • In the United States, juice is commonly introduced into the diet in the latter portion of the first year of life. Purple grape juice has a high osmolarity, which can cause osmotic diarrhea. The transport of fructose into enterocytes is not active and relatively inefficient. Apple and pear juice contain a high fructose-to-glucose ratio, and consumption of these juices can result in fructose malabsorption and diarrhea. Because sorbitol and fructose compete for the same intestinal transporter, ingesting them together may result in the malabsorption of these sugars.
  • GI tract symptoms: GI tract symptoms are common in patients with malabsorption syndromes, and symptoms range from mild abdominal gaseous distention to severe abdominal pain and vomiting. Chronic or recurrent diarrhea is by far the most common symptom.
    • Abdominal distention and watery diarrhea, with or without mild abdominal pain, associated with skin irritation in the perianal area due to acidic stools are characteristic of carbohydrate malabsorption syndromes.[5]
    • Periodic nausea, abdominal distention and pain, and diarrhea are common in patients with chronic Giardia infections.
    • Vomiting, with moderate-to-severe abdominal pain and bloody stools, is characteristic of protein sensitivity syndromes or other causes of intestinal injury (eg, inflammatory bowel disease).
    • Recurrent abdominal pain has been implicated as a symptom of dietary disorders, although psychological variables that relate to an elevated anxiety level have clouded the certainty of this relationship. Malabsorption syndromes can definitely cause abdominal pain or irritability (particularly seen in celiac disease).
    • Failure to identify the cause of malabsorption can result in the misdiagnosis of a physiologic syndrome as a behavioral disorder. Some dietary items may cause symptoms only when they are taken alone or with other specific dietary items.
    • Poor appetite is common in food sensitivity syndromes. The child becomes conditioned to refuse foods that cause inflammatory reactions of the intestine. However, this is not typically obvious in celiac disease. Malabsorption syndromes not associated with inflammatory reactions typically cause an increase in appetite (eg, cystic fibrosis), unless the associated abdominal gaseous distention hampers intake and induces early satiety.
  • Stool characteristics
    • Patients with toddler's diarrhea often have loose stools with undigested food particles. This should not be taken to imply the presence of true malabsorption.
    • Frequent loose watery stools may indicate carbohydrate intolerance.
    • Pasty or loose foul-smelling stools indicate fat malabsorption, also termed steatorrhea. This symptom is commonly seen in Giardia infections, enterokinase deficiency, hepatic and pancreatic dysfunction, and protein sensitivity syndromes.
    • Bloody stools are seen in patients with protein sensitivity syndromes and not in disaccharidase and pancreatic enzyme deficiencies or in patients with giardiasis.
  • Other symptoms
    • Systemic symptoms, including weakness, fatigue, and failure to thrive, are systemic consequences of chronically poor nutrient absorption. Malabsorption of carbohydrates, fats, or proteins can cause failure to thrive, whereas folate and B-12 malabsorption result in macrocytic anemia.
    • Patients with abetalipoproteinemia develop retinitis pigmentosa and ataxia because of chronic fat-soluble vitamin malabsorption and deficiency (vitamins A and E).


See the list below:

  • In the absence of GI tract symptoms, malabsorption syndromes should be considered during the workup for failure to thrive, malnutrition, poor weight gain, or delayed puberty. Signs of malnutrition discovered during physical examination, such as reduced muscle and fat mass, atrophic tongue changes, or enlarged liver or spleen, have been reported in children with chronic malabsorption. Malabsorption syndromes should be suspected in infants with weight loss or little weight gain since birth and in infants with low weight and weight-for-height percentiles. By definition, toddler's diarrhea does not cause failure to thrive, unless anxious parents intervene by imposing unnecessary dietary restrictions that result in lower caloric intake.
  • Dehydration caused by a diarrhea that is induced by a malabsorption syndrome is not common, but, when it occurs, dehydration can cause serious morbidity and mortality. Assess each patient for signs, symptoms, and severity of dehydration. Lethargy, depressed consciousness, sunken anterior fontanel, dry mucous membranes, sunken eyes, poor skin turgor, and delayed capillary refill are all signs of dehydration.
  • Borborygmi, a significant increase in peristaltic activity, can be detected audibly and with tactile palpation. This is associated with decreased intestinal transient time.
  • Large numbers of stools result in a constant wet diaper in young children. Failure to properly dry the buttocks and perianal area results in erythema, skin irritation, and skin breakdown, with evidence of bleeding seen in the diaper or in stool.
  • Protein sensitivity may be associated with an eczematous rash.


See the list below:

  • Carbohydrate malabsorption: Starch molecules are primarily digested by salivary and pancreatic amylase, but glucoamylase in the intestinal brush boarder also assists in digestion.
    • Pancreatic insufficiency impedes the digestion of large starch molecules.
    • Absence or reduction of the brush border disaccharidases causes selective carbohydrate malabsorption.
    • Transient reduction of these enzymes is common after an infection in the intestine, particularly a viral infection, because intestinal villi and microvilli may be damaged.
    • Glucoamylase and maltase are most resistant to the depleting effects of mucosal injury that result from infection, whereas lactase is the most sensitive because of its predominant distribution near the tips of the villi.
    • Lack of sucrase and isomaltase is, by far, the most frequent congenital enzyme deficiency. This enzyme deficiency is inherited in an autosomal recessive manner.
    • Congenital lactase deficiency is exceedingly rare, but adult-type lactase deficiency (also called adult-type hypolactasia) is very common in some ethnic groups.
    • A congenital deficiency in the glucose galactose transporter (SGLT-1) is inherited in an autosomal recessive manner.
    • Take care when diagnosing lactose or another complex carbohydrate intolerance because many complex carbohydrates are broken down into glucose.
    • Small bowel bacterial overgrowth of normal flora alters the intraluminal metabolism of carbohydrates and results in their malabsorption. This entity should also be suspected in children with diarrhea-predominant irritable bowel syndrome.[6] Bacteria ferment carbohydrates into smaller osmotically active molecules and organic acids. Increased osmolarity causes fluid from systemic circulation to enter the intestinal lumen, resulting in diarrhea. Organic acids stimulate motility and may directly injure the intestinal mucosa. Fermentation eliminates the reducing substances and lowers the pH of the stool. The production of lactate and short-chain fatty acids in the human colon can result in systemic acidosis. In particular, a syndrome of D-lactic acidosis may develop when specific bacteria that are capable of producing this uncommon and poorly cleared D isomer of lactate exist in the intestinal flora.
    • Bile acids are usually recycled by enterohepatic circulation. Many factors can prevent this recirculation. Bacterial overgrowth of normal flora and growth of abnormal flora are the most common causes of altered intraluminal metabolism of bile acids. Anaerobes and Staphylococcus aureus deconjugate bile acids, which impedes their active reabsorption by the terminal ileum into the portal circulation for reuptake by the liver. A congenital deficiency in the sodium–bile acid cotransporter results in primary bile acid malabsorption. The resulting diminished transport of bile acids from the intestinal lumen allows intestinal flora to deconjugate bile acids.
    • Deconjugated bile acids directly inhibit the carbohydrate transporters, reduce intraluminal pH levels, and damage the enterocyte. They may also directly stimulate the colon to secrete fluid, contributing to diarrhea.
  • Fat malabsorption
    • Increased delivery of fat to the colon results in diarrhea and soft, pasty, foul-smelling stools. However, the gas causes stools to float. Consequences include the malabsorption of fat-soluble vitamins A, D, E, and K and insufficient energy intake due to the high energy value of dietary lipids.
    • Exocrine pancreatic insufficiency is the principal condition that results in severe fat malabsorption.[7] Pancreatitis, pancreatic cancer, pancreatic resection, cystic fibrosis, Shwachman-Diamond syndrome, Johnson-Blizzard syndrome, and Pearson syndrome can all result in pancreatic insufficiency. Significant obstructive biliary or cholestatic liver disease or extensive intestinal mucosal disease, such as occurs in celiac disease, may also result in severe steatorrhea.
    • Impaired bile production or secretion is seen in liver or biliary tract disease. Inflammation or resection of the ileum impedes enterohepatic circulation, which results in a reduced bile acid pool. Bacterial overgrowth in the small bowel deconjugates bile acids, thereby inactivating their ability to help lipids form a micelle. These syndromes result in moderate lipid malabsorption.
    • Abetalipoproteinemia is a rare disorder with autosomal recessive inheritance. Absence of the lipoproteins results in cytoplasmic lipid accumulation in the enterocyte. Lymphatic transport of long-chain fats is impaired in patients with abetalipoproteinemia, lymphangiectasia, and protein-losing enteropathy, resulting in moderate fat malabsorption.
  • Protein malabsorption
    • Protein malabsorption is a fairly common result of exocrine pancreatic enzyme deficiency, as occurs in patients with cystic fibrosis.
    • Protein malabsorption that results from congenital enterokinase deficiency is well described but rare.
    • Creatorrhea, loss of protein in the stool (ie, protein-losing enteropathy), is often caused by the leakage of protein from the serum due to inflammation of the mucosa, as in Crohn disease, celiac disease, and protein sensitivity syndromes. Congenital lymphangiectasia, a developmental disorder in which dilation and dysfunction of intestinal lymphatics occurs, often in association with limb edema (Milroy disease), may present with severe protein-losing enteropathy without mucosal injury.
  • Vitamin malabsorption
    • Malabsorption of vitamin B-12 and folate is associated with tropical spruce, a disorder that is acquired after travel to tropical areas.
    • Vitamin B-12 is absorbed in the ileum, and absorption requires an intrinsic factor made in the gastric parietal cell. Intrinsic factor deficiency that results from atrophic gastritis or absence (from resection) or disease of the terminal ileum (the predominant site of active B-12) results in vitamin B-12 malabsorption.
Contributor Information and Disclosures

Stefano Guandalini, MD Founder and Medical Director, Celiac Disease Center, Chief, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Chicago Medical Center; Professor, Department of Pediatrics, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine

Stefano Guandalini, MD is a member of the following medical societies: American Gastroenterological Association, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, European Society for Paediatric Gastroenterology, Hepatology & Nutrition, North American Society for the Study of Celiac Disease

Disclosure: Received consulting fee from AbbVie for consulting.


Richard E Frye, MD, PhD Associate Professor, Department of Pediatrics, University of Arkansas for Medical Sciences

Richard E Frye, MD, PhD is a member of the following medical societies: American Academy of Neurology, Child Neurology Society, International Neuropsychological Society, American Academy of Pediatrics

Disclosure: Nothing to disclose.

M Akram Tamer, MD Professor, Program Director, Department of Pediatrics, University of Miami, Leonard M Miller School of Medicine

M Akram Tamer, MD is a member of the following medical societies: American Medical Association, Florida Medical Association

Disclosure: Nothing to disclose.

Catherine D Newland, MD Pediatric Gastroenterology Fellow, Comer Children’s Hospital, University of Chicago

Catherine D Newland, MD is a member of the following medical societies: American Academy of Pediatrics, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

B UK Li, MD Professor of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Medical College of Wisconsin; Attending Gastroenterologist, Director, Cyclic Vomiting Program, Children’s Hospital of Wisconsin

B UK Li, MD is a member of the following medical societies: Alpha Omega Alpha, American Gastroenterological Association, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

Disclosure: Nothing to disclose.

Chief Editor

Carmen Cuffari, MD Associate Professor, Department of Pediatrics, Division of Gastroenterology/Nutrition, Johns Hopkins University School of Medicine

Carmen Cuffari, MD is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, Royal College of Physicians and Surgeons of Canada

Disclosure: Received honoraria from Prometheus Laboratories for speaking and teaching; Received honoraria from Abbott Nutritionals for speaking and teaching.

Additional Contributors

Eric S Maller, MD 

Eric S Maller, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society of Transplant Surgeons, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

Disclosure: Nothing to disclose.

  1. Siddiqui Z, Osayande AS. Selected disorders of malabsorption. Prim Care. 2011 Sep. 38(3):395-414; vii. [Medline].

  2. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003 Feb 10. 163(3):286-92. [Medline].

  3. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009 Jul. 137(1):88-93. [Medline]. [Full Text].

  4. Meyer R, Venter C, Fox AT, Shah N. Practical dietary management of protein energy malnutrition in young children with cow's milk protein allergy. Pediatr Allergy Immunol. 2012 Mar 22. [Medline].

  5. Abenavoli L, Proietti I, Vonghia L, et al. Intestinal malabsorption and skin diseases. Dig Dis. 2008. 26(2):167-74. [Medline].

  6. Scarpellini E, Giorgio V, Gabrielli M, et al. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr. 2009 Sep. 155(3):416-20. [Medline].

  7. Bruno MJ, Haverkort EB, Tytgat GN, van Leeuwen DJ. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am J Gastroenterol. 1995 Sep. 90(9):1383-93. [Medline].

  8. Ford GA, Preece JD, Davies IH, Wilkinson SP. Use of the SeHCAT test in the investigation of diarrhoea. Postgrad Med J. 1992 Apr. 68(798):272-6. [Medline]. [Full Text].

  9. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009 Oct. 30(7):707-17. [Medline].

  10. Mokrowiecka A, Daniel P, Slomka M, Majak P, Malecka-Panas E. Clinical utility of serological markers in inflammatory bowel disease. Hepatogastroenterology. 2009 Jan-Feb. 56(89):162-6. [Medline].

  11. Ritchie BK, Brewster DR, Davidson GP, Tran CD, McNeil Y, Hawkes JS. 13C-sucrose breath test: novel use of a noninvasive biomarker of environmental gut health. Pediatrics. 2009 Aug. 124(2):620-6. [Medline].

  12. Gabrielli M, D'angelo G, Di Rienzo T, Scarpellini E, Ojetti V. Diagnosis of small intestinal bacterial overgrowth in the clinical practice. Eur Rev Med Pharmacol Sci. 2013 Dec. 17 Suppl 2:30-5. [Medline].

  13. Rizzello CG, De Angelis M, Di Cagno R, et al. Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease. Appl Environ Microbiol. 2007 Jul. 73(14):4499-507. [Medline].

  14. [Guideline] Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005 Jan. 40(1):1-19. [Medline].

  15. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006. 130:S78-90. [Medline].

  16. Lauritano EC, Gabrielli M, Scarpellini E, et al. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci. 2009 Mar-Apr. 13(2):111-6. [Medline].

  17. Kumpf VJ. Pharmacologic Management of Diarrhea in Patients With Short Bowel Syndrome. JPEN J Parenter Enteral Nutr. 2014 Jan 24. [Medline].

  18. Volta U, Granito A, Fiorini E, et al. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci. 2008 Jun. 53(6):1582-8. [Medline].

  19. Adachi JA, DuPont HL. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders. Clin Infect Dis. 2006 Feb 15. 42(4):541-7. [Medline].

  20. Cavataio F, Guandalini S. Cow's milk allergy. Guandalini S, ed. Essential Pediatric Gastroenterology. McGraw-Hill; 2005. 175-92.

  21. Cole CR, Ziegler TR. Small bowel bacterial overgrowth: a negative factor in gut adaptation in pediatric SBS. Curr Gastroenterol Rep. 2007 Dec. 9(6):456-62. [Medline].

  22. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008 Jun. 27(3):328-39. [Medline].

  23. Fonnesu C, Giovinale M, Verrecchia E, et al. Gastrointestinal amyloidosis: a case of chronic diarrhoea. Eur Rev Med Pharmacol Sci. 2009 Mar. 13 Suppl 1:45-50. [Medline].

  24. Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology. 2006. 130 (2 Suppl 1):S16-28. [Medline].

  25. Green PH, Jabri B. Celiac disease. Annu Rev Med. 2006. 57:207-21. [Medline].

  26. Guandalini S, Dincer AP. Nutritional management in diarrhoeal disease. Baillieres Clin Gastroenterol. 1998. 12:697-717. [Medline].

  27. Gupte GL, Beath SV, Kelly DA, et al. Current issues in the management of intestinal failure. Arch Dis Child. 2006. 91:259-64. [Medline].

  28. Kneepkens CM, Hoekstra JH. Chronic nonspecific diarrhea of childhood: pathophysiology and management. Pediatr Clin North Am. 1996 Apr. 43(2):375-90. [Medline].

  29. Longo N, Elsas LJ. Human glucose transporters. Adv Pediatr. 1998. 45:293-313. [Medline].

  30. Love MW, Dawson PA. New insights into bile acid transport. Curr Opin Lipidol. 1998 Jun. 9(3):225-9. [Medline].

  31. Maldonado J, Gil A, Narbona E, Molina JA. Special formulas in infant nutrition: a review. Early Hum Dev. 1998 Dec. 53 Suppl:S23-32. [Medline].

  32. Montalto M, Curigliano V, Santoro L, et al. Management and treatment of lactose malabsorption. World J Gastroenterol. 2006. 12:187-91. [Medline].

  33. Montalto M, Santoro L, D'Onofrio F, Curigliano V, Visca D, Gallo A, et al. Classification of malabsorption syndromes. Dig Dis. 2008. 26(2):104-11. [Medline].

  34. Nakamura T, Takeuchi T, Tando Y. Pancreatic dysfunction and treatment options. Pancreas. 1998 Apr. 16(3):329-36. [Medline].

  35. Robayo-Torres CC, Quezada-Calvillo R, Nichols BL. Disaccharide digestion: clinical and molecular aspects. Clin Gastroenterol Hepatol. 2006. 4:276-87. [Medline].

  36. Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann''s disease). Orphanet J Rare Dis. 2008 Feb 22. 3:5. [Medline]. [Full Text].

  37. Weiss B, Skourikhin Y, Modan-Moses D, Broide E, Fradkin A, Bujanover Y. Is adult height of patients with celiac disease influenced by delayed diagnosis?. Am J Gastroenterol. 2008 Jul. 103(7):1770-4. [Medline].

  38. Zanchi C, Di Leo G, Ronfani L, Martelossi S, Not T, Ventura A. Bone metabolism in celiac disease. J Pediatr. 2008 Aug. 153(2):262-5. [Medline].

The small intestine is a major site of absorption.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.